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The aim of this study was to assess and to compare the role of HFE polymorphisms and other genetic factors in
variation in iron stores. Blood samples were obtained from 3,375 adult male and female twins (age range 29–82
years) recruited from the Australian Twin Registry. There were 1,233 complete pairs (562 monozygotic and 571
dizygotic twins). Serum iron, transferrin, transferrin saturation with iron, and ferritin were measured, and the HFE
C282Y and H63D genotypes were determined. The frequency of the C282Y allele was .072, and that of the H63D
allele was .141. Significant sources of variation in the indices of iron status included age, sex, age-sex interaction,
body-mass index, and both the C282Y and H63D genotypes. The iron, transferrin, and saturation values of CC
and CY subjects differed significantly, but the ferritin values did not. After correction for age and body-mass index,
23% and 31% of the variance in iron, 66% and 49% of the variance in transferrin, 33% and 47% of the variance
in transferrin saturation, and 47% and 47% of the variance in ferritin could be explained by additive genetic
factors, for men and women, respectively. HFE C282Y and H63D variation accounted for !5% of the corrected
phenotypic variance, except for saturation (12% in women and 5% in men). We conclude that HFE CY and HD
heterozygotes differ in iron status from the CC and HH homozygotes and that serum transferrin saturation is more
affected than is serum ferritin. There are highly significant effects of other as-yet-unidentified genes on iron stores,
in addition to HFE genotype.
Introduction
Iron is an essential element, mainly because of its role
within oxygen-binding and respiratory proteins. How-
ever, it also gives rise to dangers such as generation of
free radicals and consequent tissue damage. Regardless
of its cause, high liver iron content leads to an increased
risk of cirrhosis, hepatoma, porphyria cutanea tarda,
and other liver diseases (Hsing et al. 1995; Stal 1995;
Bonkovsky et al. 1996; Mandishona et al. 1998; Sam-
pietro et al. 1999). Increased iron also favors infection
(Brock 1994); in addition, it has been reported as a risk
factor for atherosclerosis (Kiechl et al. 1997; Tuomainen
et al. 1998), although this link is controversial (Danesh
and Appleby 1999). Iron deposition in the pancreas may
play a role in some cases of non–insulin-dependent di-
abetes (Kwan et al. 1998), although this, too, is contro-
versial and is probably dependent on the clinical pop-
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ulation studied. Iron deficiency, on the other hand, can
proceed to iron-deficiency anemia and other adverse
conditions, including poorer pregnancy outcomes and,
possibly, impaired intellectual development in infancy
(see Baynes 1994). Therefore, there are hazards associ-
ated with both insufficient and excessive iron content in
the body. Iron levels within cells and extracellular fluids
are strongly regulated through controls on absorption,
storage, transport, and utilization.
Factors Influencing Iron Stores
Many factors are known to affect iron status, includ-
ing dietary availability and the biological processes of
intake, absorption, and loss. Since urinary excretion is
slight and apparently is not regulated, control of ab-
sorption provides the main safeguard against both iron
overload and iron depletion. Variation between individ-
uals may be the result of combinations of—and inter-
actions between—genetic and environmental differ-
ences. Dietary availability of iron (through choice of
diet), iron absorption, absorption-diet interactions, and
variation in iron loss (particularly in women) are all
potentially subject to genetic influences. Little is cur-
rently known about the genetic factors that may influ-
ence iron stores in humans, except for hemochromatosis.
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Hemochromatosis
There has recently been substantial progress in deter-
mination of the molecular and cellular bases of iron
metabolism, because of characterization of the gene mu-
tation mainly responsible for hemochromatosis (Feder
et al. 1996). This autosomal recessive condition with
sex-dependent penetrance causes iron overload and iron
deposition in the tissues, as a result of inappropriately
high absorption of iron. The clinical consequences of
this iron overload occur both more commonly and at
an earlier age in men than in women (Powell et al. 1994);
that the consequences of iron overload occur less com-
monly in women may generally be ascribed to the fact
that women have physiological blood loss and lower
iron stores.
At least 85% of cases of genetic hemochromatosis are
believed to be the result of homozygosity for the C282Y
mutation in the HFE gene at chromosome 6p. The
C282Y form of the gene encodes a protein that does not
bind b2-microglobulin and that, therefore, is not pre-
sented on the cell surface, where the wild-type protein
associates with transferrin receptors. This is believed to
interfere with the regulation of iron absorption from the
intestine (Zoller et al. 1999). The role, if any, of the
slightly more-frequent H63D polymorphism in the same
gene is unclear, but the findings of some reports (Aguilar
Martinez et al. 1997; Sanchez et al. 1998; Brissot et al.
1999; Moirand et al. 1999) have suggested that com-
pound heterozygotes (CY/HD) are occasionally affected
by hemochromatosis. Current clinical and scientific
questions relating to this disease have been summarized
elsewhere (Bacon et al. 1999).
Polymorphic Variation in HFE
The dysfunctional C282Y form of the HFE gene is
common among populations of European descent, with
reported frequencies of 5%–15% (see Burt et al. 1998;
Jouanolle et al. 1998; Lucotte 1998; Murphy et al. 1998;
Nielsen et al. 1998; Merryweather-Clarke et al. 1999).
These estimates are consistent with the findings of earlier
studies (Edwards et al. 1988; Leggett et al. 1990), which
detected homozygotes in unselected populations through
identification of a phenotype of high serum ferritin and
high transferrin saturation with iron.
There are uncertainties about the natural history of
homozygosity for the Y allele and about how fre-
quently—and at what age—it leads to clinically sig-
nificant iron overload. To assess the desirability of
population screening for hemochromatosis, it is im-
portant to undertake population-based studies of the
prevalence and the effects of the Y allele. Presymp-
tomatic but genetically affected subjects, or “obligate
heterozygotes,” that, in the past, were detected by
screening of relatives of patients with hemochroma-
tosis may differ from C282Y heterozygotes or from
Y homozygotes in the general population in significant
ways.
Since the C282Y polymorphism is both common
and, at least in homozygous individuals, potentially
harmful, it may persist through conferment of some
selective advantage in the heterozygous state—most
obviously, through a reduced risk of iron deficiency.
Some reports of subjects ascertained, by means of hap-
lotype studies within affected families, to be hetero-
zygous for the hemochromatosis gene (Bulaj et al.
1996) and of subjects genotyped as being heterozy-
gous for the HFE C282Y mutation (Burt et al. 1998;
Datz et al. 1998; Moirand et al. 1999) have found a
positive effect on iron stores and, by inference, a re-
duced risk of iron deficiency.
HFE as a Contributor to Genetic Variation
It is unlikely that HFE variation is the only genetic
factor affecting iron stores; most quantitative charac-
teristics with a genetic component appear to be affected
by multiple genes. Moreover, variation in the penetrance
and age at onset of symptoms of hemochromatosis may
be caused by the additive or interactive effects of other
genes. Similarly, some individuals may be more vulner-
able to iron deficiency because of the actions of uniden-
tified genes.
The aims of the present study were to determine the
allele frequencies of C282Y and H63D in a large group
of presumably healthy subjects and to compare iron
stores in subjects with differing CY and HD genotypes.
The study was performed on twin subjects, so that her-
itability—the sum of all gene effects—could be estimated
and compared with the effects of HFE variation. This
design allowed us to determine whether a search for
further iron-storage genes is necessary.
We have assessed iron stores by measurement of iron,
transferrin, and ferritin in blood serum and by calcu-
lation of transferrin saturation with iron. Data on a
number of covariates have been included in the analysis,
to determine the relative importance of HFE genotype,
age, sex, and ethnicity with regard to iron stores within
the Australian population.
Subjects and Methods
The subjects participating in the present study were re-
cruited through the Australian Twin Registry, initially
for participation in questionnaire- and interview-based
studies of alcohol use, alcohol dependence, and com-
orbid psychiatric conditions (Heath et al. 1997). The
subjects who form the basis of this study subsequently
volunteered for a study of genetic and genotype effects
on health-related phenotypes. They gave informed con-
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sent to be interviewed and, subsequently, to undergo
blood collection and to allow use of their blood samples
in the study. The studies were approved by appropriate
ethics committees.
In all, 3,375 subjects provided blood samples from
1993–1996. At the time of blood collection, the sub-
jects’ height and weight were measured, and the subjects
completed a brief questionnaire that included questions
about their grandparents’ countries of birth and ances-
try. The time of blood collection was recorded, and the
subjects reported the time of their last meal. All subjects
were twins, but, in some cases, only one member of a
twin pair provided blood. Consistent with the geo-
graphic distribution of the Australian population, most
subjects who gave blood lived in either Adelaide, Bris-
bane, Melbourne, or Sydney or lived close enough to
those cities to attend blood-collection sessions held
there. A minority of blood samples were collected in
more-remote sites; in these instances, blood was deliv-
ered to the laboratory within 24 h. Serum was separated
and was stored at 70C until it was analyzed, and
DNA was extracted from EDTA or from heparin blood.
Zygosity of all complete pairs was determined by typing
of at least eight highly polymorphic microsatellite mark-
ers, the HFE genotypes, and the ABO, Rh, and MNS
blood group systems.
Measurements of serum iron, transferrin, and ferritin
were performed, by use of Roche methods, on a Hitachi
917 analyzer, and the percentage of iron saturation of
transferrin was calculated as 100{[ mol iron per liter]/m
[(g tranferrin per liter) # 25]}. HFE genotypes for
C282Y and H63D were determined by means of
PCR, and allele-specific oligonucleotide hybridization
(L.M.C. and E.C.J., personal communication), and
those samples that were typed as YY by use of this
method were confirmed with the use of modified prim-
ers, as described elsewhere (Jeffrey et al. 1999).
Complete results were obtained for 3,005 subjects,
all phenotypic results were obtained for 3,118 subjects,
and both HFE polymorphisms were typed for 3,176
subjects. For a further 254 subjects that were from mon-
ozygotic (MZ) twin pairs where only one of the pair
underwent HFE genotyping, the genotype could be in-
ferred from that of their twin. With the addition of this
information, complete data were available for a total
of 3,044 subjects, including 578 unpaired subjects (226
men and 352 women) and 1,233 pairs of twins (481
MZ female pairs, 181 MZ male pairs, 243 dizygotic
[DZ] female pairs, 89 DZ male pairs, and 239 DZ male/
female pairs).
Ancestry data provided by the subjects were used to
test for differences in C282Y or H63D allele frequencies
between ethnic groups. Given the nature of the popu-
lation studied, the main available contrast was between
subjects of English and Celtic ancestry. For each subject,
information on the ancestry of four grandparents was
provided, and the grandparents were divided into four
groups (English, Celtic [from Ireland, Scotland, and
Wales], Other European, and Non-European). Ancestry
of the individual subjects could therefore be 100% at-
tributable to one category, or it could be represented as
a combination of categories—for example, 25% English
and 75% Celtic, or 50% Celtic and 50% Other Eu-
ropean. Multiple regression was used to test for the
effects of the four ethnicity variables on the average
number of Y and D alleles carried by each subject.
Initial investigation of the effects of known or sus-
pected covariates was conducted by means of analysis
of variance. This also generated means for each sub-
group. These means and the size of the differences be-
tween subgroups were not affected by the twin nature
of the sample. However, significance tests were biased
in a nonconservative direction because of the sharing
of genes within twin pairs. Statistical problems resulting
either from missing data or from the use of twin subjects
were overcome by means of maximum-likelihood meth-
ods. Models of sources of variation were fitted to values
for the dependent variables (serum iron, transferrin, sat-
uration, and ferritin) by use of the Mx 1.47c program,
which also allows for modeling of the expected values
of individuals in terms of such covariates as sex, age,
and genotype.
The Mx program was used to test a succession of
models of increasing complexity for their goodness of
fit to the data. At each step, a covariate or gene effect
was added to the model, and the increase in log like-
lihood was used in a test for improvement of fit. At2x
each step, the variance components and the twin-pair
correlations corrected for covariates were estimated.
Models of genetic and environmental sources of var-
iation were fitted to the data, with simultaneous cor-
rection for covariate effects. This was done both with
and without incorporation of effects from the measured
genotypes (HFE C282Y and H63D), and the relative
importance of HFE polymorphisms and of other, un-
known genes was estimated. Models were initially tested
with additive genetic (A), nonshared environmental (E),
and either dominant genetic (D) or shared environmen-
tal (C) sources of variation. The ACE or ADE models
were then compared with models containing only A and
E (AE models), and the AE models were compared with
models containing either C and E or E alone. Sex-spe-
cific A and E components of variation were then com-
pared with the common AE model (Zhu et al. 1999).
To confirm that the associations between genotype
and phenotype were not the result of population strat-
ification, contrasts within twin pairs (that share their
ancestry) and between pairs (where stratification may
be present) were tested as described elsewhere (Fulker
et al. 1999). Finally, sources of covariation between
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Table 2
Relationship between Ancestry of Subjects and the Probability of
Carrying a C282Y or H63D Allele
ANCESTRY
OF SUBJECTSa
PROBABILITY OF
CARRYING ALLELE
C282Y
(b  SE)b
H63D
(b  SE)b
(Constant) .120  .017 .272  .024
English .026  .022c .011  .030c
Celtic .060  .026d .083  .036d
Other European .019  .029c .066  .039c
Non-European .007  .045c .066  .061c
a As assessed from their reports on the ancestry of their
grandparents.
b b denotes the unstandardized regression coefficient from multiple
regression of the number of Y or D alleles on the percentage of ancestry
in each of the four ancestry groupings; SE = standard error.
c Not significant.
d .P ! .05
Table 1
Observed Numbers of Twin Subjects, by HFE C282Y and H63D
Genotypes
SEX OF SUBJECT
AND GENOTYPE
OBSERVED NUMBER OF
TWIN SUBJECTS, BY
HH HD DD
Male:
CC 634 266 27
CY 106 17 0
YY 3 0 0
Female:
CC 1,341 427 44
CY 251 45 0
YY 15 0 0
NOTE.—Numbers are not corrected for gene sharing within twin
pairs.
iron, transferrin, and ferritin were tested in a multivar-
iate model incorporating both common and specific ge-
netic and environmental sources of variation.
Results
HFE Allele and Haplotype Frequencies
Genotyping results, by sex, for the C282Y and H63D
polymorphisms in the HFE gene are shown in table 1.
These are the observed numbers for all subjects, without
controlling for gene sharing within twin pairs. Allele and
haplotype frequencies were also estimated by taking only
one subject from each twin pair, with the addition of
the subjects whose twins did not participate. This re-
sulted in Y allele frequencies of .0669  .0064 and
.0725  .0050 and in D allele frequencies of .1565 
.0093 and .1351  .0065, in men and women, respec-
tively (all estimates are standard error). The genotype
frequencies did not deviate significantly from Hardy-
Weinberg equilibrium. Maximum-likelihood estimation
of the haplotype frequencies from the twin genotypes,
by use of the program ASSOCIAT, showed that they did
not differ significantly between men and women. The
estimated frequencies were as follows: CH, .788; YH,
.069; CD, .143; and DY, 0. The CY and HD loci were
in significant linkage disequilibrium (women 2x =
, men ; both ). Both the absence219.62 x = 11.37 P ! .001
of subjects with CY/DD, YY/HD, or YY/DD and the
zero estimate for the frequency of the DY haplotype are
consistent with findings from previous reports indicating
that Y and D alleles have never been found on the same
chromosome.
The estimated effects of ethnic origin on the frequency
of CY and HD are shown in table 2. The regression
equations predicted that subjects who had 100% Celtic
ancestry would have, on average, 0.180 Y alleles and
0.355 D alleles per person, resulting in allele frequencies
of 9.0% and 17.8%, respectively. For subjects with no
reported Celtic ancestry, the predicted allele frequencies
were 6.0% for the Y allele and 13.6% for the D allele,
and the effects of Celtic ancestry were marginally sig-
nificant ( without correction for duplicationP ! .05
within twin pairs) in each case.
Indices of Iron Stores
Frequency distributions of each variable (iron, trans-
ferrin, saturation, and ferritin) were assessed by use of
normal probability plots, and ferritin results were log-
transformed before further analysis. All references to fer-
ritin are therefore log-transformed values, unless oth-
erwise stated.
Initial assessments included tests for the effects of time
of blood collection, age, sex, and obesity, without taking
into account the twin structure of the cohort. Serum iron
showed significant variation with regard to the time of
day at which blood was collected (fig. 1), but it showed
no significant effect of time since the last meal. Trans-
ferrin and ferritin showed no significant diurnal or fast-
ing variation. Each of the four variables showed highly
significant differences in means between men and
women, and all but saturation showed changes with age
in women. Among men, only transferrin differed sig-
nificantly between the age groups. (Details of these tests
of significance are not shown, since results of the more-
appropriate model-fitting tests are described in the fol-
lowing paragraph.) Effects of age and sex on saturation
and ferritin are shown in figure 2. Body-mass index
(BMI) had highly significant effects on saturation and
ferritin, respectively, in both men (R = 0.148 and
0.145) and women (R = 0.128 and 0.138); all effects
are significant at . Obesity tended to increaseP ! .001
ferritin, but it decreased transferrin saturation with iron.
Division of the subjects into quintiles of BMI showed
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Figure 1 Effect of the time of blood collection on serum iron
results in men and women in the present study. Points indicate means,
and error bars show  1 SEM. Distributions of times of blood col-
lection, for both men and women, are shown (inset).
that there was a continuous trend across all quintiles,
rather than a major effect of an extremely low or high
BMI (data not shown).
These effects were confirmed in the results of mod-
eling with use of the Mx program. There was signif-
icant male/female heterogeneity in overall variances
for iron, transferrin, and saturation ( = 37.3, 52.9,2Dx1
and 23.2, respectively; all P ! .001) but not (after the
log-transformation) for ferritin ( ; not statis-2Dx = 1.21
tically significant). The means for men and women
differed significantly for all variables. In women, age
had strong effects on transferrin and saturation and,
to a lesser extent, on iron, but the effects of age were
weaker in men. Addition of age2—to allow for non-
linear effects of age—produced little improvement, ex-
cept for transferrin, among men. BMI had significant
effects on all four variables, but it should be remem-
bered that these effects were different (opposite) for
iron and ferritin (see preceding paragraph). Collection
time had major effects on iron and, consequently, on
saturation.
C282Y and H63D Genotypes and Iron Stores
Because of the sex differences in iron-store markers
and allele frequencies and because of the difference in
age effects between men and women, the effects of ge-
notype on the dependent variables were initially assessed
separately for men and women. These results for satu-
ration and ferritin are shown in figure 3. In men, the
C282Y genotype had significant effects on iron, trans-
ferrin, and saturation but not on ferritin. For iron and
saturation, values increased across the groups CCr
CYrYY, but the value for transferrin decreased. How-
ever, it should be noted that only one YY man was in-
cluded in this analysis. In women, all four variables were
significantly affected by the CY genotype. Again, iron,
saturation, and ferritin increased—but transferrin de-
creased—across the groups CCrCYrYY.
For the H63D genotype, only iron and saturation
showed significant effects in men. The mean values were
lowest in HH subjects and were highest in DD subjects.
Among women, only saturation showed a significant
H63D effect. However, the effects of the C282Y and
H63D alleles on iron-store markers could be confounded
because of the linkage disequilibrium between them.
Subjects carrying the D allele (the putative high–iron-
storage form) were less likely to be carrying the Y allele.
These initial results were supported by Mx model
fitting. After adjustment for the covariates described
above, genotype effects were added. First, the effects of
the C282Y polymorphism were tested under the as-
sumption of additive effects (i.e., that the effect of two
Y alleles would be twice as great as that of one allele).
This produced highly significant results for all four var-
iables (step 1; table 3). Next, the effect of the H63D
polymorphism was tested under the same additive as-
sumption; again, highly significant results were obtained
for iron and saturation (step 2). A minor effect was
found for transferrin, but none was found for ferritin.
It should be noted that we found these H63D effects
after accounting for the C282Y effect. In step 3, addition
of H63D without C282Y produces a lesser (but still
significant) change in the fit of the models for iron and
saturation, and this difference in the HD effect size can
be ascribed to the interaction of the C282Y and H63D
gene frequencies.
In steps 1–3, additive allelic effects of HFE variation
were assumed. Further models were tested that examined
the effects of genotype and that allowed for the possi-
bility of dominance (i.e., that the heterozygote value may
be closer to one homozygote than to the other). Step 4
allows for a difference between the CC and CY geno-
types. The change in values shows that, for iron,2x
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Figure 2 Effects of age group and sex on (A) saturation and (B)
ferritin. Points indicate means, and error bars show 1 SEM. Mean
values are adjusted for collection time and for BMI. Sex had highly
significant effects on both variables, and age affected ferritin in women.
transferrin, and saturation—but not for ferritin—there
is a significant difference between the CC homozygote
and the CY heterozygote. In step 5, allowing for a dif-
ference between CY and YY produces significant im-
provement in fit for all four variables, consistent with
the results shown in figure 3. Comparison of this two-
stage process, which allows for unequal effects of the
first and second Y allele (dominance), with use of the
model in which equal effects (additivity) are assumed,
shows that the change between the dominance-effects2x
model at step 5 and at baseline is much greater for every
variable than is the change between the additive-ef-2x
fects model at step 1 and at baseline.
Similarly, after adjustment for the differences in the
mean values associated with variation in the C282Y ge-
notype, steps 6 and 7 (see table 3) test for differences
between HH and HD and, then, test for additional ef-
fects of the DD genotype. HD heterozygotes showed
significant differences, compared with HH homozygotes,
for iron and saturation but not for transferrin or ferritin
(step 6), whereas the DD genotype showed minor effects
for iron, transferrin, and saturation but, again, none for
ferritin (step 7). For this polymorphism, the model per-
mitting dominance effects of two D alleles showed no
significant improvement over the additive model (the
sum of values for steps 6 and 7 is not appreciably2x1
greater than the value for step 2). Steps 8 and 9 are2x1
similar to step 3, in that C282Y effects are not included.
Again, the HH/HD differences were more detectable
when CY effects were included (in a comparison of 2x1
for step 8 vs. that for step 6), and the effects of DD were
slight (step 9 vs. step 7).
Are HFE Effects Due to Population Stratification?
Results of the Fulker test, which assessed population
stratification as a possible cause of some of the genotype/
iron-stores associations, are shown in table 4. Since this
technique makes use of complete DZ pairs only, the
number of subjects is reduced; for a constant effect size,
this analysis will have less power to detect allelic effects
than will the full Mx model. Nevertheless, the genetic
associations that were found to be significant in the
model fitting (see preceding section, and table 3) were
confirmed as resulting from pleiotropic allelic effects
rather than from population stratification. This is tested
in model 5 (presented in table 4), in which dropping
within-pair differences produces a significant deterio-
ration for iron (for C282Y and H63D), transferrin (for
C282Y only), and saturation (for C282Y and H63D).
For ferritin, for which the effect size is smaller than that
for the other analytes, the reduction in sample size ob-
tained by using only complete DZ pairs renders the as-
sociation no longer significant.
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Figure 3 Effects of HFE C282Y and H63D genotypes on (A) saturation and (B) ferritin. Mean values are adjusted for sex, age (in women),
BMI, and collection time. Columns indicate means; error bars show 1 SEM. *** ; * . NS = not significant.P ! .001 P ! .05
Genetic and Environmental Sources of Variation in
Iron-Store Markers
At each step of the model-fitting process described
above, the within-pair correlations, by zygosity, were
estimated after adjustment for the covariates and gen-
otypic effects in the model. Details of these correlations
at two important stages are given in table 5: first, after
adjustment for the covariates but before introduction of
the measured genotypes and, second, after inclusion of
the CY and HD genotypes. Models of genetic and en-
vironmental sources of variation were fitted to these data
by use of Mx.
In all cases, models containing either unshared envi-
ronmental effects only (E) or unshared and shared en-
vironmental effects (CE) were strongly rejected. Models
containing unshared and shared environmental effects
together with additive genetic effects (ACE) showed no
significant improvement when compared with models
containing only unshared environmental and additive
genetic effects (AE). Allowing different A and E com-
ponents of variance for men and women (AmEm/AfEf)
showed highly significant improvements, compared with
the common AE model, for all four variables. No further
improvement in fit was gained by relaxation of the con-
straint on perfect correlation between additive genetic
effects in men and women; from this, we can conclude
that there is no evidence for nonscalar sex limitation of
gene effects on these variables (Neale and Cardon 1992).
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Table 3
Tests for Effects of HFE Genotype on Indices of Iron Stores, Including Data from Both Male
and Female Subjects
STEP MODELb
COMPARED
MODELc
a IN2Dx1
Iron Transferrin Saturation Ferritin
1 Y only Baseline 39.2* 64.5* 115* 9.4**
2 Y  D 1 25.3* 6.5*** 36.1* .7d
3 D only Baseline 18.0* 2.4d 21.2* .2d
4 CY Baseline 15.9* 39.4* 45.8* 1.3d
5 CY  YY 4 47.2* 35.1* 144* 26.5*
6 CY  YY  HD 5 22.2* 1.4d 27.3* .0d
7 CY  YY  HD  DD 6 4.3*** 6.9** 9.9** 2.0d
8 HD only Baseline 16.6* .2d 16.3* .0d
9 HD  DD 8 2.7d 3.9*** 5.2*** 1.6d
a Maximum-likelihood estimates created by means of the computer program Mx.
b The improvements in fit, as genotypic information is added, are tested for each variable. Y
is the additive effect of C282Y mutations, and D is the additive effect of H63D mutations. CY,
YY, HD, and DD are genotypic effects and allow for unequal (dominance) effects of the hetero-
zygous and homozygous states.
c The baseline model allows for effects of age, sex, BMI, and collection time.
d Not significant.
* .P ! .001
** .P ! .01
*** .P ! .05
Models allowing for unshared environmental effects
together with both additive and dominance genetic ef-
fects (ADE) gave no improvement in fit, compared with
the AE models, except possibly for saturation, before
allowing for effects of measured HFE genotypes. For the
data allowing for covariate effects alone, the ADE/AE
change in was almost significant ( ;2 2x Dx = 3.52 P =1
). On the basis of this saturation ADE model, before.06
the HFE variation was omitted, almost one-third (32%)
of the variance was estimated to be the result of dom-
inance effects, and this dropped sharply (to 14%, not
significantly different from zero) after allowance was
made for the effects ofHFEC282Y and H63D variation.
This is consistent with the dominance effects of the CY
genotype, as shown in table 3.
Sex-dependent heritability estimations on the AmEm/
AfEf models, before allowing for measured genotypes
(i.e., with C282Y and H63D effects included among
the additive genetic effects), were 23% and 31% for
iron, 66% and 49% for transferrin, 33% and 47%
for saturation, and 47% and 47% for saturation, for
men and women, respectively. Although the HFE
polymorphisms had significant effects on the pheno-
typic variables, the background genetic effects were
substantially greater in each case. Proportions of var-
iance caused by environmental, non-HFE genetic, and
HFE effects on iron, transferrin, saturation, and fer-
ritin are shown in figure 4.
Sources of Covariation between Markers of Iron Stores
There were highly significant—and moderately strong
—correlations between results for transferrin and ferritin
(men0.358, women0.413; both ). Iron wasP ! .001
weakly correlated with transferrin in men (0.121; P !
) but not in women (0.024; ) and with fer-.001 P = .274
ritin in both sexes (men 0.070, ; women 0.228,P = .024
). To determine whether these correlations wereP ! .001
caused by genetic factors, environmental factors, or
both, a Cholesky model (Neale and Cardon 1992) of
the sources of residual polygenic genetic and environ-
mental variation in iron, transferrin, and ferritin was
also computed. Values of path coefficients were similar,
with or without adjustment for HFE effects in the means
model. Genes with a primary influence on iron had only
minor effects on ferritin and transferrin, whereas most
of the polygenic variation for transferrin was specific to
transferrin. The negative relationship between ferritin
and transferrin is modulated through both genes and
specific environment.
Discussion
The main aim of the present study was to assess the
effects of the HFE C282Y and H63D polymorphisms
on iron stores in the general population and to compare
their magnitude with other genetic effects through use
of a twin-study design. The results lead to three main
conclusions about HFE polymorphisms and iron stores:
(1) both C282Y and H63D affect aspects of iron stores
or iron metabolism, even when they are present in the
heterozygous state; (2) HFE effects on serum ferritin are
minor, compared with effects on serum iron and on the
saturation of serum transferrin with iron; and (3) other
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Table 4
Fulker Test for Within-Pair Associations between Iron-Related
Phenotypes and the HFE C282Y and H63D Polymorphisms in
Complete DZ Twin Pairs Only
Model 2a Model 3b Model 4c Model 5c,d
Description Drop ADs ab  aw Drop ab Drop aw
Compared model Full Full 3 4
Ddf 1 1 1 1
Iron:
Dx2 CY 7.83* 1.35 2.63 6.55*
Dx2 HD 12.1* .33 6.36* 6.07**
Transferrin:
Dx2 CY 21.8* .17 15.3* 6.64*
Dx2 HD 1.11 .00 .65 .46
Saturation:
Dx2 CY 29.5* .74 15.1* 15.1*
Dx2 HD 17.2* .25 9.26* 8.16*
Ferritin:
Dx2 CY 2.13 .94 .33 2.74
Dx2 HD .07 .10 .10 .00
a Tests for the deterioration in the fit of the model brought about
by constraining allelic deviations to zero across all individuals. ADs =
allelic deviations.
b Partitions ADs into those occurring between (ab) and within (aw)
sib pairs.
c ADs partitioned in model 3 are set to zero. See footnote b for
definition of “ab.”
d ADs partitioned in model 3 are set to zero. Significant aw (see
footnote b for definition) demonstrates that ADs are not solely the
result of population stratification.
* .P ! .01
Table 5
Maximum-Likelihood Estimates of Twin Correlations, before and
after Correction for the Effects of HFE Genotypes in the Model for
the Means
VARIABLE AND
CORRECTION
MAXIMUM-LIKELIHOOD ESTIMATES OF
TWIN CORRELATIONS FOR
MZ DZ
Both
Female
Both
Male
Both
Female
Both
Male
Male and
Female
Iron:
Covariates only .317 .222 .100 .149 .130
With CY and HD .275 .203 .120 .138 .131
Transferrin:
Covariates only .481 .665 .311 .350 .245
With CY and HD .453 .658 .307 .371 .224
Saturation:
Covariates only .488 .329 .106 .222 .170
With CY and HD .389 .296 .138 .219 .142
Ferritin:
Covariates only .463 .501 .300 .098 .170
With CY and HD .452 .498 .314 .091 .176
NOTE.—All correlations are adjusted for effects of the covariates
sex, age, BMI, and collection time.
unknown genes have effects on iron stores that are con-
siderably greater than those of HFE.
Allele and Haplotype Frequencies
The C282Y and H63D gene frequencies found among
the subjects were consistent with findings from recent
reports from Europe, and there was some evidence of
association between the Y allele and Celtic ancestry. In
a review of geographic variation inHFE gene frequencies
(Lucotte 1998), the highest frequency of the Y allele was
found among populations in the more-northern parts of
Europe. Despite some difficulties with the definition of
Celtic populations, high frequencies have been reported
from Ireland, Scotland, Wales, and Brittany. In surveys
concentrating on Ireland, Murphy et al. (1998) found a
Y allele frequency of .099, and Ryan et al. (1998) re-
ported a frequency of .140.
Our results also show some association between Celtic
ancestry and the H63D allele, although this has a more
widespread occurrence than does C282Y. In Europe, re-
ported frequencies of the D allele include .11 in Germany
(Nielsen et al. 1998), .13 in Denmark (Steffensen et al.
1998), .14 in Ireland (Murphy et al. 1998), and .22 in
Spain (Sanchez et al. 1998). Other reported frequencies
of the D allele are .14 in New Zealand (Burt et al. 1998)
and .16 among whites in America (McDonnell et al.
1999). These are all similar to our frequency of .14.
Effects of HFE Variation
The most-prominent effect of HFE genotype was the
major effect of homozygosity for the C282Y allele. As
expected, YY women had much higher values for iron,
saturation, and ferritin and had lower results for trans-
ferrin than did either CC or CY subjects (fig. 3). The
only YY man for whom quantitative results were avail-
able also had results consistent with high iron stores.
This large effect of the second Y allele shows the quan-
titative dominance of the C allele and is consistent with
the recessive inheritance of the clinical condition of he-
mochromatosis. This finding was apparent in the major
improvement in fit for all variables when an effect of
YY (additional to that of CY) was introduced into the
model of sources of variation. Comparison of ADE and
AE models of sources of variation, before adjustment
for HFE, also suggests a dominant genetic component
in the variation in iron and saturation (although purely
additive models are not rejected). These estimated dom-
inant genetic components are reduced after the effects
of CY and HD are omitted. Thus, the results of variance-
component analysis are consistent with the fixed-effect
modeling of genotypic contribution to expected values
(means; fig. 3) and with clinical experience of the in-
heritance of hemochromatosis.
Compound heterozygotes with CY/HD have been re-
ported by some studies as presenting with clinical he-
mochromatosis. For this reason, the results for CY/HD
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Figure 4 Proportions of variance ascribable to HFE gene vari-
ation, the additive effects of other genes, and the nonshared environ-
mental effects in men and women. The total variance in women has
been standardized to 100 for each variable.
subjects were examined for evidence of additive or syn-
ergistic effects of the two HFE polymorphisms. In wom-
en, the effects were approximately additive for both sat-
uration and ferritin. In men, the effects were nonaddi-
tive, with ∼10% increases in both saturation and ferritin
being associated with CY or HD alone (compared with
CC/HH subjects) and with increases of 40%–45%
above this baseline occurring in the compound hetero-
zygotes. However, there was no evidence that the com-
bination of Y and D alleles could produce iron accu-
mulation similar to that found in YY subjects. For
comparison, the saturation and ferritin results in YY/
HH subjects were 240%–390% of those in CC/HH sub-
jects. Elsewhere in Australia, Olynyk et al. (1999) have
reported that compound heterozygotes (those carrying
both the C282Y and the H63D mutations) had higher
transferrin saturation than either heterozygotes with the
C282Y mutation alone or subjects with neither muta-
tion; ferritin values were also greater in the compound
heterozygotes, but only among the men. These findings
suggest that compound heterozygotes are unlikely to be
affected, unless other genetic or dietary risks are sub-
stantial. This is consistent with the findings from clinical
reports; compound heterozygotes will be approximately
twice as common as YY homozygotes, but, in studies
that have genotyped patients diagnosed before this ge-
notyping became available, they comprise only a small
percentage of subjects with apparent hereditary hemo-
chromatosis.
Any finding of association between a genotype with
a frequency that varies among populations and a phe-
notype that may vary for a number of reasons raises the
question of whether there is a true cause-and-effect re-
lationship between the allele and the phenotype or
whether some form of population stratification is caus-
ing the apparent association. Specifically, an association
between high iron stores and the Y allele could be the
result of this allele being more common among Irish
Australians, with some unrelated genetic or nongenetic
factor causing higher iron stores in this group. Apart
from considerations of biological plausibility, these pos-
sibilities can be distinguished statistically in studies that
use related subjects, such as siblings (in this case, the
DZ twin pairs). Application of this test involves testing
for differences in genotype and phenotype within pairs
of siblings, and the results (table 4) confirmed that not
only CY but, also, HD has genuine effects on serum iron
and transferrin saturation. The absence of significant
results for ferritin is because restriction of the analysis
to complete DZ pairs has reduced the power to detect
the comparatively small effect.
The genotype-phenotype associations found in this
study are similar to those reported in other community-
based studies. In New Zealand, Burt et al. (1998) found
increased iron and transferrin saturation in both C282Y
and H63D heterozygotes. Mean ferritin values were also
slightly higher than those in the CC/HH group, but this
did not reach statistical significance. In C282Y hetero-
zygotes, Datz et al. (1998) reported increased iron, sat-
uration, and, interestingly, hemoglobin. H63D was not
typed. Their subjects were all women (age range 18–40
years) who were recruited from health-care staff in Aus-
tria. These studies and the present study show that HFE
polymorphisms affect iron stores even among hetero-
zygotes but that ferritin is less affected than is transferrin
saturation.
HFE Variation and Selection
As mentioned above, the persistence of at least the
C282Y mutation, with its clear disease association in
homozygous men, suggests some advantage for heter-
ozygotes. The most-obvious possibility is protection
against iron deficiency, which not only puts the adult
individual (particularly women) at risk but which also
has adverse effects on pregnancy outcome.
From our model, we can estimate the probability of
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each genotype being iron deficient, which we define as
falling below a threshold of 15% for saturation and, for
ferritin, 20 mg/liter. For a woman of age 40 years, we
predict that 18% of normal CC/HH women will fall
below the saturation threshold, whereas only 8% of CY
women and none of the YY women will have such a
decrease. There is also some protective effect of the
H63D polymorphism, since 12% of HD women and 9%
of DD women are predicted to be deficient. Protection
against low ferritin is less dramatic; 21% of normal
women are predicted to have ferritin concentrations !20
mg/liter, whereas 18% of CY women and 1% of YY
women will have such concentrations; HD women show
no protection (21%), but only 16% of DD women have
low ferritin.
A similar calculation can be performed to assess the
probability of iron overload, estimated for men of age
50 years; as with the calculations assessing women, a
BMI of 25 and a midmorning collection time are as-
sumed for the calculations assessing men. The following
probabilities of exceeding a saturation value of 50%
were estimated: CC/HH, 2%; CY, 7%; YY, 99%; HD,
4%; and DD, 6%. For a ferritin value 1500, the prob-
abilities were CC/HH, 15%; CY, 18%; YY, 73%; HD,
15%; and DD, 20%.
Translating these values into selective advantage can
only be speculative, but it will be seen that HFE C282Y
and H63D genotypes have substantial influence on the
chance of low transferrin saturation in women and that
the C282Ygenotype has such an influence on the chance
of high transferrin saturation in men. The effects on
ferritin are smaller, but each polymorphism may affect
iron overload in men. However, bearing in mind that,
in our sample, there was only one YY man for whom
we had quantitative data, we must be very cautious
about the estimates of iron-overloaded men predicted
from our model.
It is likely that, throughout most of the past 15 cen-
turies, these polymorphisms have had effects on survival
and reproductive fitness. Whether the sex-associated
risks and advantages are now in equilibrium is un-
known. The effects will vary according to the chance of
iron deficiency or overload in the two sexes and in the
population in question, and this might account for ge-
ographic differences in gene frequency. If the C282Y
mutation arose in a single founder within the last 60–70
generations (Ajioka et al. 1997), then this implies an
increase of ∼20% per generation. Even if the age of the
mutation is underestimated because of drastically re-
duced recombination in the major-histocompatibility-
complex region, it seems likely that there has still been
a very substantial selective advantage for the Y allele.
Which Aspect of Iron Metabolism Is Most Affected?
One surprising finding was that the effects of C282Y
variation on iron, transferrin, and saturation were
greater than the effect on ferritin, at least for the het-
erozygotes. This raises the question of which is the best
index both of body iron stores and the risks of deficiency
or overload. There is evidence that serum ferritin is well
correlated with body iron reserves (Skikne et al. 1990).
Although it may also be increased as an acute-phase
protein during infection or inflammation, these would
be uncommon among subjects in the present study. Se-
rum iron, on the other hand, is not regarded as a good
measure of iron stores, although the saturation calcu-
lated from the combination of iron and transferrin
(which increases in iron deficiency and decreases in iron
overload) may be better. Part of the problem with use
of serum iron as a measure of iron status is its within-
person variation, and the correction for time of blood
collection would have partly compensated for this.
Although the details of howHFE variation affects iron
absorption and iron stores are not fully worked out, it
seems that the primary effect of the Y mutation is to
change the interactions between transferrin, the trans-
ferrin receptor, and the HFE gene product (Salter-Cid et
al. 1999). Effects on iron-transport proteins in the in-
testine (Zoller et al. 1999) and, ultimately, on body iron
stores and ferritin, are consequences of this. From this
perspective, the fact that HFE variation accounts for a
greater proportion of variance in transferrin saturation
than in ferritin is not so surprising, although it does
imply that there are other mechanisms that can keep
down ferritin levels in CY heterozygotes, even when the
availability of iron bound to transferrin in the circulation
and at the cell surface is relatively high.
Perspective on HFE Mutations
Although the C282Y variant of HFE has major effects
on iron stores in the homozygous state and produces a
potentially fatal disease in the long term, and although
both the C282Y and H63D polymorphisms lead to
highly significant variation in indices of iron reserves
within the general population, they are not the only
genes affecting iron status. The remaining differences
between MZ and DZ correlations, after allowing for
HFE effects (table 5), show that other genes account for
∼45% of the phenotypic variation in serum ferritin and
for 30% of the variation in transferrin saturation.
The possibility of achieving this perspective is one of
the strengths of combining twin or family studies with
measurement of specific genotypes, and, in this case, it
shows that there are other genes to be found. Such genes
may or may not affect the penetrance or age at onset of
hemochromatosis, and they may or may not be linked
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with the HFE locus. There are likely to be a number of
genes with individually small and additive effects. Lo-
cation of such genes may be achieved through linkage
studies with further polymorphic markers in the chro-
mosome 6 major histocompatibility complex/HFE re-
gion, or it may require a genomewide search. The S65C
polymorphism in HFE (Mura et al. 1999) may influence
iron status, but its low frequency (∼.02) suggests that it
can have only minor effects on population variation.
Finally, we may consider the effects of genes affecting
iron stores on diseases other than hemochromatosis or
iron-deficiency anemia. It is known that high hepatic
iron stores are associated with many types of liver dis-
ease, from viral hepatitis to alcoholic cirrhosis to he-
patocellular carcinoma, although the direction of causal
relationships is not yet clear (George et al. 1999). Recent
studies (Roest et al. 1999; Tuomainen et al. 1999) have
strengthened the proposed association between iron and
cardiovascular disease. Given the differences in iron
stores produced by the known forms of HFE variation
and, even more strongly, by other unknown genes, this
may be a route to understanding genetic differences in
susceptibility to a range of more-common diseases.
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